Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal

por von Linstow, Christian U., Gan-Or, Ziv, Brundin, Patrik
Publicado 2020

Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?

por von Linstow, Christian U., DeLano-Taylor, Merritt, Kordower, Jeffrey H., Brundin, Patrik
Publicado 2020

Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine

por Severino, Maurizio, Sivasaravanaparan, Mithula, Olesen, Louise Ø., von Linstow, Christian U., Metaxas, Athanasios, Bouzinova, Elena V., Khan, Asif Manzoor, Lambertsen, Kate L., Babcock, Alicia A., Gramsbergen, Jan Bert, Wiborg, Ove, Finsen, Bente
Publicado 2018

T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils

por George, Sonia, Tyson, Trevor, Rey, Nolwen L., Sheridan, Rachael, Peelaerts, Wouter, Becker, Katelyn, Schulz, Emily, Meyerdirk, Lindsay, Burmeister, Amanda R., von Linstow, Christian U., Steiner, Jennifer A., Galvis, Martha L. Escobar, Ma, Jiyan, Pospisilik, J. Andrew, Labrie, Viviane, Brundin, Lena, Brundin, Patrik
Publicado 2021